| 体内研究: |
SSR504734 (i.p. and p.o.; 1-100 mg/kg; once) treatment shows good oral bioavailability. SSR504734 (i.p.; 30 mg/kg; once) induces a rapid and significant decrease of specific glycine uptake. SSR504734 (i.p.; 10 mg/kg; once) increases extracellular levels of Glycine in the prefrontal cortex (PFC) of freely moving rats. |
| 参考文献: |
1. Ronan Depoortère, et al. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology. 2005 Nov;30(11):1963-85. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.309 ml |
11.547 ml |
23.095 ml |
| 5 mM |
0.462 ml |
2.309 ml |
4.619 ml |
| 10 mM |
0.231 ml |
1.155 ml |
2.309 ml |
| 50 mM |
0.046 ml |
0.231 ml |
0.462 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |